Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 1, 1996, Pages 20-28

  Barletta, J P ^a   Angella, G ^a   Balch, K C ^a   Dimova, H G ^a   Stern, G A ^a   Moser, M T ^a   Van Setten, G B ^a   Schultz, G S ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

corneal ulceration; metalloproteinases; protease inhibitors; Pseudomonas keratitis

Indexed keywords

BACTERIAL ENZYME; ILOMASTAT; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; PROTEINASE;

ADJUVANT CHEMOTHERAPY; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA ULCER; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; GRAM NEGATIVE INFECTION; KERATITIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CORNEA; CORNEAL ULCER; CULTURE MEDIA; DIPEPTIDES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE INFECTIONS, BACTERIAL; FEMALE; METALLOENDOPEPTIDASES; OPHTHALMIC SOLUTIONS; PROTEASE INHIBITORS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RABBITS;

EID: 0030024137     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Stern GA, Schultz GS. The pathogenesis of bacterial infections of the cornea. In: Tasman W, Jaeger EA, eds. Foundations of Clinical Ophthalmology. Philadelphia: Lippincott-Raven Publishers; in press.
2. Brown SI, Bloomfield SE, Tam WI. The cornea-destroying enzyme of Pseudomonas aeruginosa. Invest Ophthalmol. 1974;13:174-180.
3. Kawaharajo K, Abe C, Homma JY, Kawano M, Gotoh E, Tanaka N, et al. Corneal ulcers caused by protease and elastase from Pseudomonas aeruginosa. Jpn J Exp Med. 1974;44:435-442.
4. Kessler E, Kennah H, Brown SI. Pseudomonas protease: Purification, partial characterization and its effect on collagen, proteoglycan, and rabbit corneas. Invest Ophthalmol Vis Sci. 1977;16:488-497.
5. Kreger AS, Gray LD. Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage. Infect Immun. 1978;19:630-648.
6. Kessler E, Mondino BJ, Brown SI. The corneal response to Pseudomonas aeruginosa: Histopathological and enzymatic characterization. Invest Ophthalmol Vis Sci. 1977;16:116-125.
7. Morihara K. Production of elastase and proteinase by Pseudomonas aeruginosa. J Bacteriol. 1964;88:745-757.
8. Okuda K, Morihara K, Atsumi Y, et al. Complete nucleotide sequence of the structural gene for alkaline proteinase from Pseudomonas aeruginosa IFO 3455. Infect Immun. 1990;58:4083-4088.
9. Jensen SE, Phillippe L, Teng Tseng J, Stemke GW, Campbell JN. Purification and characterization of exocellular proteases produced by a clinical isolate and a laboratory strain of Pseudomonas aeruginosa. Can J Microbiol 1980;26:77-86.
10. Yamamoto S, Fukushima J, Atsumi Y, et al. Cloning and characterization of elastase structural gene from Pseudomonas aeruginosa IFO 3455. Biochem Biophys Res Comm. 1988;152:1117-1122.
11. Heck LW, Morihara K, Mcrae WB, Miller EJ. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase. Infect Immun. 1986; 51:115-118.
12. Twining SS, Davis SD, Hyndiuk RA. Relationship between proteases and descemetocele formation in experimental Pseudomonas keratitis. Curr Eye Res. 1986;5:503-510.
13. Macartney HW, Tschesche H. Latent and active human polymorphonuclear leukocyte collagenases: Isolation, purification, and characterization. Eur J Biochem. 1983;130:71-78.
14. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 1989;264:17213-17221.
15. Morel F, Berthier S, Guillot M, et al. Human neutrophil gelatinase is a collagenase type IV. Biochem Biophys Res Comm. 1993;191:269-274.
16. Watanabe H, Hattori S, Katsuda S, Nakanishi I, Nagai Y. Human neutrophil elastase: Degradation of basement membrane components and immunolocalization in the tissue. J Biochem. 1990;108:753-759.
17. Gadek JE, Fells GA, Wright DG, Crystal RG. Human neutrophil elastase functions as a type III collagen 'collagenase.' Biochem Biophys Res Comm. 1980;95: 1815-1822.
18. Busiek DF, Ross FP, McDonnell S, Murphy G, Matrisian LM, Welgus HG. The matrix metalloproteinase matrilysin (pump) is expressed in developing human mononuclear phagocytes. J Biol Chem. 1992;267:9087-9092.
19. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI, Welgus HG. Neutral proteinases of human mononuclear phagocytes: Cellular differentiation markedly alters cell phenotypes for serine proteinases, metalloproteinases and tissue inhibitor of metalloproteinases. J Immunol. 1991;146:1286-1293.
20. Senior RM, Campbell EJ, Lindis JA, Cox FR, Kuhn C, Koren HS. Elastase of U-937 Monocytelike cells: Comparisons with elastase derived from human monocytes and neutrophils and murine macrophage-like cells. J Clin Invest. 1982;69:384-393.
21. Fini ME, Girard MT. Expression of collagenolytic/ gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci. 1990;31:1779-1788.
22. Burns FR, Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci. 1989;30:1569-1575.
23. Burns FR, Paterson CA, Gray RD, Wells JT. Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide. Antimicrob Agents Chemother. 1990;34:2065-2069.
24. Kessler E, Spierer A, Blumberg S. Specific inhibition of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes. Invest Ophthalmol Vis Sci. 1983;24:1093-1097.
25. Spierier A, Kessler E. The effect of 2-mercaptoacetyl-L-phenylalanyl-L-leucine, a specific inhibitor of Pseudomonas aeruginosa elastase, on experimental Pseudomonas keratitis in rabbit eyes. Curr Eye Res. 1984;3:645-650.
26. Schultz GS, Strelow S, Stern GA, et al. Treatment of alkali-injured rabbit corneas with a synthetic inhibitor of matrix metalloproteinase. Invest Ophthalmol Vis Sci. 1992;33:3325-3331.
27. Grobelney D, Poncz L, Galardy RE. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry. 1992;31:7152-7154.
28. Birkedal-Hansen H, Taylor RE. Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Comm. 1982; 107:1173-1178.
29. Dahlman B, Reinauer H. Purification and some properties of alkaline proteinase from rat skeletal muscle. Biochem J. 1978;171:803-810.
30. Laibson PR. Annual review: Cornea and sclera. Arch Ophthalmol. 1972;88:553-574.
31. Liesegang TJ. Bacterial and fungal keratitis. In: Kaufman HE, Barron BA, McDonald MB, Waltman SR, eds. The Cornea. New York: Churchill-Livingstone; 1988;217-270.
32. Brown SI, Akiya S, Weller CA. Prevention of the ulcers of the alkali-burned cornea. Arch Ophthal. 1969;82:95-97.
33. Seedor JA, Perry HD, McNamara TF, Golub LM, Buxton DF, Guthrie DS. Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbits. Arch Ophthalmol. 1987;105:268-271.
34. Slansky HH, Berman MB, Dohlman CH, Rose J. Cysteinc and acetylcysteine in the prevention of corneal ulcerations. Ann Ophthalmol. 1970;2:488-491.
35. Levy JH, Katz HR. Effect of systemic tetracycline on the progression of Pseudomonas aeruginosa keratitis in the rabbit. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1988;29:172.
36. Matsumoto K, Shams NBK, Hanninen LA, Kenyon KR. Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase. Curr Eye Res. 1992;11:1105-1109.
37. Twinning SS, Loushin GP, Zhou X, Mahnke LA. Isolation and characterization of a new proteinase from Pseudomonas aeruginosa. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1993;34:847.
38. Ohman DE, Burns RP, Iglewski BH. Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J Infect Diseases. 1980; 142:547-555.
39. Kernacki KA, Hobden JA, Hazlett LD, Fridman R, Berk RS. In vivo bacterial production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995;36:1371-1378.